Search for: "Amneal Pharmaceuticals LLC" Results 1 - 20 of 48
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
5 Sep 2018, 10:44 am by Jay W. Belle Isle
The ruling, following a four-day trial in Delaware federal court, is a victory for Robins Kaplan’s client, Amneal Pharmaceuticals LLC. [read post]
21 Dec 2014, 8:55 pm by Patent Docs
• Defendant: Amneal Pharmaceuticals LLC... [read post]
11 May 2020, 9:59 pm by Patent Docs
Amneal Pharmaceuticals LLC") is most frequently rebutted by the doctrine of prosecution history estoppel ("Pharma Tech Solutions, Inc. v. [read post]
29 Nov 2015, 9:54 pm by Patent Docs
• Defendants: Amneal Pharmaceuticals LLC; Amneal Pharmaceuticals of New York LLC; Par Pharmaceutical, Inc. [read post]
30 Apr 2018, 10:30 am by Doyle, Barlow & Mazard PLLC
On April 27, 2018, the FTC announced that Amneal Pharmaceuticals LLC (“Amneal”) may complete its acquisition of an equity share in Impax Laboratories Inc. [read post]
30 Apr 2018, 10:30 am by Doyle, Barlow & Mazard PLLC
On April 27, 2018, the FTC announced that Amneal Pharmaceuticals LLC (“Amneal”) may complete its acquisition of an equity share in Impax Laboratories Inc. [read post]
17 Mar 2014, 9:59 pm by Patent Docs
.; Intas Pharmaceuticals Ltd.; Amneal Pharmaceuticals LLC; Amneal Pharmaceuticals of New York, LLC; Amneal Pharmaceuticals Co. [read post]
3 Jan 2016, 9:33 pm by Patent Docs
Amneal Pharmaceuticals LLC 2:15-cv-01697; filed September 3, 2015 in the District Court of Nevada • Plaintiffs: Spectrum Pharmaceuticals, Inc.; University of Strathclyde • Defendant: Amneal Pharmaceuticals LLC Infringement of U.S. [read post]
31 Jan 2016, 7:57 pm by Patent Docs
• Defendant: Amneal Pharmaceuticals LLC Infringement of U.S. [read post]
11 Apr 2016, 9:27 pm by Patent Docs
Amneal Pharmaceuticals, LLC 1:15-cv-00964; filed October 22, 2016 in the District Court of Delaware • Plaintiffs: Unimed Pharmaceuticals, LLC; Besins Healthcare Inc.; Besins Healthcare Luxembourg SARL • Defendant: Amneal Pharmaceuticals, LLC Infringement of U.S. [read post]
1 Nov 2015, 9:57 pm by Patent Docs
Par Pharmaceutical Inc. et al. 1:15-cv-00679; filed August 3, 2015 in the District Court of Delaware • Plaintiffs: Janssen Biotech Inc.; Janssen Oncology Inc.; Janssen Research & Development LLC • Defendants: Amneal Pharmaceuticals LLC; Amneal Pharmaceuticals of New York LLC; Par Pharmaceutical Inc.; Par Pharmaceutical Companies Inc. [read post]
8 Oct 2016, 3:25 am by Gregory B. Williams
Plaintiffs, Endo Pharmaceuticals Inc. and Mallinckrodt LLC, filed these patent infringement actions against defendants Amneal Pharmaceuticals, LLC, Amneal Pharmaceuticals of New York, LLC (collectively, “Amneal”), Teva Pharmaceuticals USA, Inc. and Barr Laboratories, Inc. [read post]
23 Dec 2014, 12:26 pm
Amneal is a pharmaceutical company that develops, manufactures, markets and distributes generic pharmaceutical products for sale in the United States. [read post]
15 Jan 2015, 9:59 pm by Patent Docs
("Roxane"), and Amneal Pharmaceutical, LLC ("Amneal") (together, "petitioners") against patents owned by Jazz Pharmaceutical, Inc. [read post]
30 Jan 2017, 7:15 pm by FDABlog HPM
District Court for the District of Columbia, ANDA applicant Amneal Pharmaceuticals LLC (“Amneal”) alleges that FDA incorrectly ruled that Amneal forfeited eligibility for 180-day exclusivity for generic versions of NAMENDA XR (memantine HCl) Extended-release Capsules, 7 mg, 14 mg, 21 mg, and 28 mg. [read post]